Mersana Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 11/14/2024 | 19.36 M | $36.60 M | 0.00% | 15.82% |
| NEXTECH INVEST LTD. | 11/14/2024 | 12.07 M | $22.81 M | 26.68% | 9.86% |
| VR ADVISER, LLC | 11/14/2024 | 11.33 M | $21.41 M | 0.00% | 9.25% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 8.66 M | $16.37 M | 0.00% | 7.08% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.62 M | $16.30 M | 100.00% | 7.04% |
| VANGUARD GROUP INC | 11/13/2024 | 7.18 M | $13.57 M | 7.09% | 5.86% |
| CITADEL ADVISORS LLC | 11/14/2024 | 4.41 M | $8.34 M | 60.79% | 3.60% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 3.05 M | $5.76 M | 0.00% | 2.49% |
| STATE STREET CORP | 11/14/2024 | 2.73 M | $5.15 M | 1.62% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.41 M | $4.56 M | -3.22% | 1.97% |
| JPMORGAN CHASE & CO | 11/08/2024 | 2.35 M | $4.44 M | 18.94% | 1.92% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 2.22 M | $4.20 M | -25.32% | 1.82% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.96 M | $3.70 M | 57.38% | 1.60% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.82 M | $3.43 M | 100.00% | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.59 M | $3.00 M | -36.58% | 1.30% |
| MORGAN STANLEY | 11/14/2024 | 1.36 M | $2.58 M | -39.97% | 1.11% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 1.31 M | $2.47 M | 0.00% | 1.07% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 1.30 M | $2.46 M | 11,695.18% | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 1.20 M | $2.27 M | -27.84% | 0.98% |
| EXOME ASSET MANAGEMENT LLC | 12/13/2024 | 1.18 M | $2.23 M | 100.00% | 0.96% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 1.09 M | $2.05 M | 0.00% | 0.89% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.02 M | $1.93 M | -30.24% | 0.84% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 993,046 | $1.88 M | 104.50% | 0.81% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 992,000 | $1.87 M | 0.00% | 0.81% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 990,036 | $1.87 M | 519.65% | 0.81% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 877,043 | $1.66 M | -11.64% | 0.72% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 618,305 | $1.17 M | 16.03% | 0.51% |
| UBS OCONNOR LLC | 11/14/2024 | 570,029 | $1.08 M | 4.73% | 0.47% |
| HEALTHINVEST PARTNERS AB | 11/12/2024 | 538,621 | $1.02 M | 191.30% | 0.44% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 535,819 | $1.01 M | 100.00% | 0.44% |
| CLARIVEST ASSET MANAGEMENT LLC | 11/12/2024 | 500,498 | $1.01 M | 0.00% | 0.41% |
| BARCLAYS PLC | 11/19/2024 | 494,516 | $934,000 | 32.68% | 0.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 492,719 | $931,239 | -65.98% | 0.40% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 486,800 | $920,052 | -32.32% | 0.40% |
| UBS GROUP AG | 11/14/2024 | 473,527 | $894,966 | 1,253.59% | 0.39% |
| WOODLINE PARTNERS LP | 11/14/2024 | 433,552 | $819,413 | -70.45% | 0.35% |
| JANE STREET GROUP, LLC | 11/15/2024 | 417,451 | $788,982 | 31.55% | 0.34% |
| JANE STREET GROUP, LLC | 11/15/2024 | 383,200 | $724,248 | 100.00% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 372,173 | $703,407 | -17.81% | 0.30% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 364,727 | $689,334 | 100.00% | 0.30% |
| XTX TOPCO LTD | 11/14/2024 | 347,255 | $656,312 | 185.97% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 312,623 | $590,857 | 0.00% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 300,222 | $567,420 | -59.90% | 0.25% |
| FMR LLC | 11/13/2024 | 277,740 | $524,928 | 13.17% | 0.23% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 271,774 | $514,000 | 368.90% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 259,783 | $490,990 | -62.45% | 0.21% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 233,209 | $440,765 | -1.28% | 0.19% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 189,660 | $358,457 | 8.12% | 0.15% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 186,060 | $351,653 | 0.00% | 0.15% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 182,793 | $345,479 | 100.00% | 0.15% |
Mersana Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 143 institutional investors and hedge funds held shares of Mersana Therapeutics, Inc.. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 19.36 M
Nextech Invest Ltd.: 12.07 M
VR Adviser, LLC: 11.33 M
Bain Capital Life Sciences Investors, LLC: 8.66 M
BlackRock Funding, Inc. /DE: 8.62 M
VANGUARD GROUP INC: 7.18 M
94.80% of Mersana Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 128.00 M shares in the last 24 months. This purchase volume represents approximately $207.35 M in transactions.